S. J. Antonia Et Al. , "Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC," NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.24, pp.2342-2350, 2018
Antonia, S. J. Et Al. 2018. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.24 , 2342-2350.
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., ... Kurata, T.(2018). Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.24, 2342-2350.
Antonia, S. Et Al. "Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC," NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.24, 2342-2350, 2018
Antonia, S. J. Et Al. "Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC." NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.24, pp.2342-2350, 2018
Antonia, S. J. Et Al. (2018) . "Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC." NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.24, pp.2342-2350.
@article{article, author={S. J. Antonia Et Al. }, title={Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2018, pages={2342-2350} }